The case for ketamine in treating suicidal ideation
from Psychology Today
In an article published recently in the American Journal of Psychiatry, Samuel Wilkinson and colleagues examined the effect of ketamine in reducing suicidal ideations. They utilized a technique called meta-analysis to combine data from ten clinical studies that fulfilled specific rigorous criteria. They found that a single intravenous infusion of ketamine, at doses akin to those used in other studies to treat major depression, led to a rapid decrease in suicidal ideations. Within a day, about 55 percent of individuals who received ketamine no longer had suicidal ideations, compared to 20 percent who received a placebo. This reduction in suicidal ideations lasted for at least seven days.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063